THURSDAY, NOVEMBER 23, 2017

India's health minister introduces National Framework for Malaria Elimination

The Union Minister for Health & Family Welfare in India, Shri J P Nadda, recently launched the new National Framework for Malaria Elimination 2016-2030. Read More »

Japan donates funds for vaccinations in Ebola-stricken areas

Japan recently agreed to send $18.5 million to Gavi to finance vaccination services in countries that are suffering from Ebola, the virus that recently caused a West African outbreak. Read More »

Global Fund, UN alliance progresses toward malaria elimination

The Global Fund and the U.N. Development Program in Principe and São Tomé recently agreed to continue work toward eliminating malaria. Read More »

WHO publishes update on influenza in Ukraine

The World Health Organization recently published an update about influenza rates in Ukraine. Read More »

Synthetic vaccine test shows immune response to Zika virus

Inovio Pharmaceuticals Inc. recently stated that its pre-clinical testing for the company’s synthetic vaccine designed to protect people from the Zika virus has shown a robust, durable immune response in test subjects. Read More »

Researchers present findings from Ebola vaccine trial

Researchers recently attended the American Association for the Advancement of Science’s annual meeting to present the inner workings of their recent experimental Ebola vaccine trial. Read More »

GSK seeks alternative to cold chain storage

GlaxoSmithKline (GSK) and Variation Biotechnologies, a subsidiary of VBI Vaccines Inc., recently finalized a partnership in which the company’s researchers will use a VBI technology called the LPV Platform. Read More »

Modifying antibacterial drug may benefit TB patients

Vanderbilt University scientists recently found that altering one small chemical in a current antibacterial drug may create a compound that effectively targets tuberculosis (TB) and its enzymes, improving TB treatments. Read More »

Toddler's death promotes awareness of need for MenB vaccine

The Meningitis Research Foundation (MRF) recently applauded the progress that the Meningococcal Group B (MenB) meningitis vaccine has made this year while sending heartfelt thoughts to the family and friends of Faye Burdett, who died from MenB this week. Read More »

Maryland researchers discover potential MERS treatment

Scientists at the University of Maryland School of Medicine recently found a potential new treatment for Middle East Respiratory Syndrome (MERS) that uses genetically modified cows to produce antibodies to fight the infection. Read More »

UK continues MenW vaccine campaign

Health professionals are continuing an ongoing campaign against meningococcal W in the U.K., where there has been a steep increase in cases in recent years. Read More »

Blood test could improve TB diagnosis in developing nations

Stanford University School of Medicine researchers recently discovered a gene expression “signature” that can be seen in a simple blood test, making it more affordable and efficient to manage tuberculosis (TB). Read More »

Study shows flu vaccine distribution model needs improvement

Research from Washington University in St. Louis’ Olin Business School demonstrates that the distribution and delivery system for influenza vaccines needs to be improved to avoid shortages. Read More »

Researchers encourage innovation to decrease HIV infections in Africa

Johnson & Johnson recently launched the DREAMS Innovation Challenge to encourage researchers to think of innovative ways to decrease HIV infections throughout sub-Saharan Africa. Read More »

Health care workers quickly respond to Ebola flare-up in Sierra Leone

Health care workers have quickly responded to a recent flare-up of the Ebola virus in Sierra Leone, offering families who are suffering from the flare-up relief from the disease. Read More »

Aarhus study shows how influenza virus evades immune system

An Aarhus University study demonstrates the influenza virus is able to evade detection from the immune system by masking itself and avoiding the system’s mechanism against invading viruses. Read More »

ViiV Healthcare purchases HIV R&D portfolio from Bristol-Myers Squibb

ViiV Healthcare recently finalized its acquisition of a portfolio with HIV research and development information from Bristol-Myers Squibb. Read More »

Obama administration releases details to broaden malaria initiative

President Barack Obama has already made significant changes to the anti-malaria efforts, which started 10 years ago with George W. Bush's President’s Malaria Initiative (PMI). Read More »

Vaginal ring with antiretroviral drug offers partial HIV protection

The National Institutes of Health recently conducted studies that show an antiretroviral drug within a vaginal ring may be the strongest protector for women against HIV infections. Read More »

Liberian study shows experimental Ebola vaccines are immunogenic and well-tolerated

Two investigational Ebola vaccines have been tested and proved to be immunogenic and well-tolerated among 1,500 participants in a randomized, placebo-controlled clinical trial. Read More »